Parasiticidal Efficacy of a New Formulation of Silver Nanoparticles on Trichinella spiralis in vitro
Keywords:
Trichinella spiralis, Nano-Silver, DNA damage, Electron microscopyAbstract
This research illustrates the development of a new sliver nanoparticle (Ag-NPs) formulation. Its shape, size, solubility, and stability were characterized using Scanning Electron Microscope (SEM 3D), Transmission Electron Microscope (TEM 2D), Atomic Force Microscope (AFM), and Zeta size and Zeta potential. Exposure of Trichinella spiralis adult worms to 3, 6, 9 and 12 ppm of Ag-NPs each for 3,6,12 and 24 h. In vitro revealed a direct relation between mortalities and the tested drug concentration and exposure time. Anti- T. spiralis effect of Ag-NPs was evaluated by assessing mortality rate and damage in DNA by comet assay and by SEM analysis. Mean mortalities increased from 6.66% after exposure to 3.0 ppm/1 h to 100% after exposure to 12.0 ppm/12 h. The calculated LC50 was 3.0 ppm/10 h, 6 ppm/6 h, 9.0 ppm/4 h and 12.0 ppm/ 3.30 h, while LC100 was 9.0 ppm/24 h and 12.0 ppm/12 h. DNA genotoxic damage of dead worms was directly related to Ag-NPs concentrations for 12h using comet assay as expressed by variations in the percentage of DNA in the tail segment, tail length (μm), tail moment (μm), and olive tail moment. No significant difference (p ≤ .05) between the recorded mortalities and DNA damage between that obtained using the Ag-NPs LC100 and that recorded using Albendazole (50 mg/kg B.W.) for 12 h. SEM images on dead worms revealed clear morphological alteration, multiple vesicles, and blebs, detachment of the epidermis and the sub-epidermal layer with partial sloughing of the cuticle, and loss of normal creases, ridges, and annulations. These morphological alterations were directly related to the concentration of the tested Ag-NPs. The tested new formulation of Ag-NPs appears to be effective in the control of Trichinellosis as an alternative to other resistant drugs.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Journal of Advanced Veterinary Research
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles under the following conditions: Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0).
Attribution-NonCommercial-NoDerivs
CC BY-NC-ND
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license